Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Shinji, Soga"'
Autor:
Ryo Matsunaga, Kan Ujiie, Mayuko Inagaki, Jorge Fernández Pérez, Yoshiki Yasuda, Shinya Mimasu, Shinji Soga, Kouhei Tsumoto
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Surface plasmon resonance (SPR) is widely used for antigen–antibody interaction kinetics analysis. However, it has not been used in the screening phase because of the low throughput of measurement and analysis. Herein, we proposed a high-t
Externí odkaz:
https://doaj.org/article/bc2db471440047b7834aef6961058f18
Autor:
Koji Aoyama, Ryuichi Moriya, Masahito Sato, Shinji Soga, Jotaro Suzuki, Satoshi Takeuchi, Takuya Kito
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40:6-10
Toll-like receptors (TLRs) sense microbial infection through recognition of pathogen-associated molecular patterns. For example, TLR4 responds to the lipopolysaccharide of gram-negative bacteria, whereas TLR2 recognizes a broad range of microbial lig
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 39:217-221
Toll-like receptor 4 (TLR4) plays a critical role in the innate immune system and is involved in the pathogenesis of multiple diseases. Here, we report the antagonistic and ratized antibody, 52-1H4 e2 (e2), which completely inhibited lipopolysacchari
Autor:
Masato Kiyoshi, Jose M M Caaveiro, Eri Miura, Satoru Nagatoishi, Makoto Nakakido, Shinji Soga, Hiroki Shirai, Shigeki Kawabata, Kouhei Tsumoto
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e87099 (2014)
The optimization of antibodies is a desirable goal towards the development of better therapeutic strategies. The antibody 11K2 was previously developed as a therapeutic tool for inflammatory diseases, and displays very high affinity (4.6 pM) for its
Externí odkaz:
https://doaj.org/article/0cf7920ae8224301853af57115c60f91
Autor:
Nozomi Izako, Kenji Mizuguchi, Chioko Nagao, Shigeki Kawabata, Samia Haseeb Khan, Shinji Soga, Hiroki Shirai
Publikováno v:
Proteins: Structure, Function, and Bioinformatics. 80:2426-2436
Proteins interact with different partners to perform different functions and it is important to elucidate the determinants of partner specificity in protein complex formation. Although methods for detecting specificity determining positions have been
Publikováno v:
Journal of Chemical Information and Modeling. 48:1679-1685
The idea that there should be a specific site on a protein for a particular functional small molecule is widespread. It is, however, usually not so easy to understand what characteristics of the site determine the binding ability of the functional sm
Publikováno v:
Journal of Chemical Information and Modeling. 47:2287-2292
Identification of the druggable concavity, in which drug-like molecules are highly inclined to bind, is an important step in structure-based drug design. We previously proposed an index named PLB (propensity for ligand binding), which is based on the
Autor:
Hiroki, Shirai, Catherine, Prades, Randi, Vita, Paolo, Marcatili, Bojana, Popovic, Jianqing, Xu, John P, Overington, Kazunori, Hirayama, Shinji, Soga, Kazuhisa, Tsunoyama, Dominic, Clark, Marie-Paule, Lefranc, Kazuyoshi, Ikeda
Publikováno v:
Biochimica et biophysica acta. 1844(11)
More and more antibody therapeutics are being approved every year, mainly due to their high efficacy and antigen selectivity. However, it is still difficult to identify the antigen, and thereby the function, of an antibody if no other information is
Autor:
Kazuyoshi Ikeda, Kazuhisa Tsunoyama, Dominic Clark, John P. Overington, Hiroki Shirai, Paolo Marcatili, Catherine Prades, Randi Vita, Jianqing Xu, Hirayama Kazunori, Marie-Paule Lefranc, Shinji Soga, Bojana Popovic
Publikováno v:
BBA-Biochimica et Biophysica Acta
BBA-Biochimica et Biophysica Acta, Elsevier, 2014, 1844 (11), pp.2002-2015. ⟨10.1016/j.bbapap.2014.07.006⟩
BBA-Biochimica et Biophysica Acta, Elsevier, 2014, 1844 (11), pp.2002-2015. ⟨10.1016/j.bbapap.2014.07.006⟩
More and more antibody therapeutics are being approved every year, mainly due to their high efficacy and antigen selectivity. However, it is still difficult to identify the antigen, and thereby the function, of an antibody if no other information is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4939ebc5de3b756fa9dc4c8c5e65f3c
https://hal.archives-ouvertes.fr/hal-01088585
https://hal.archives-ouvertes.fr/hal-01088585
Publikováno v:
Internal Medicine. 40:607-612
OBJECTIVE Interferon-alpha (IFN-alpha) is one of the most effective therapeutic agents for a number of hematological malignancies, including chronic myelogenous leukemia (CML). Nevertheless, its efficacy is limited because of the development of resis